<p>截至 2025 年 9 月，亚洲市场正在应对一个复杂的环境，受全球经济变化和地方发展影响，中国股市在国内流动性充裕的情况下出现上涨，而日本的指数在利率预期减弱的情况下也有所上升。在这种环境下，拥有强大内部持股的公司往往能够提供稳定性，并使管理层与股东利益保持一致，因此对寻求区域增长机会的投资者具有吸引力。</p>
<h3>亚洲高内部持股的十大成长公司</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>浙江零跑科技 (SEHK:9863)</td>
<td>14.6%</td>
<td>57.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>84.6%</td>
</tr>
<tr>
<td>PharmaResearch (KOSDAQ:A214450)</td>
<td>35%</td>
<td>30.9%</td>
</tr>
<tr>
<td>Oscotec (KOSDAQ:A039200)</td>
<td>12.7%</td>
<td>104.1%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>30.3%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>35.5%</td>
<td>34%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.5%</td>
<td>24.9%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>35.2%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>11.8%</td>
<td>50.7%</td>
</tr>
<tr>
<td>Ascentage Pharma Group International (SEHK:6855)</td>
<td>12.8%</td>
<td>91.9%</td>
</tr>
</tbody>
</table>
<p>点击这里查看我们快速增长的亚洲高内部持股公司筛选器中的 616 只股票的完整列表。</p>
<p>以下是筛选器中的一些选择。</p>
<h2>阿里巴巴健康信息技术 (SEHK:241)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> 阿里巴巴健康信息技术有限公司在中国大陆和香港运营，专注于药品直销、药品电子商务平台以及医疗和数字服务，市值为 1073.2 亿港元。</p>
<p><strong>运营：</strong> 该公司通过其药品和医疗运营的分销和开发产生了 306 亿元人民币的收入。</p>
<p><strong>内部持股：</strong> 19.3%</p>
<p><strong>收益增长预测：</strong> 每年 20.3%。</p>
<p>阿里巴巴健康信息技术的交易价格显著低于其估计的公允价值，预计年收益增长将超过 20%。尽管收入增长预测为每年 9.9% 较慢，但仍超过香港市场的平均水平。该公司过去的收益表现强劲，去年增长了 62.1%，但面临着低预测股本回报率和大量一次性项目影响收益质量的挑战。</p>
<ul>
<li>在我们的收益增长报告中更详细地了解阿里巴巴健康信息技术的潜力。</li>
<li>我们的阿里巴巴健康信息技术估值报告中的分析暗示其股价相较于估计价值被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f0d30b15-6b0d-4c3b-a813-701ae085f025/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f0d30b15-6b0d-4c3b-a813-701ae085f025/chart/earnings-and-revenue-growth"/></p>
<p>SEHK:241 截至 2025 年 9 月的收益和收入增长</p>
<h2>Raytron Technology Ltd (SHSE:688002)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Raytron Technology Co., Ltd. 专注于中国的无冷却红外成像和 MEMS 传感器技术的研发、设计、制造和销售，市值为 399.7 亿元人民币。</p>
<p><strong>运营：</strong> Raytron Technology Co., Ltd. 主要通过其在中国的无冷却红外成像和 MEMS 传感器技术运营产生收入。</p>
<p><strong>内部持股：</strong> 25.7%</p>
<p><strong>收益增长预测：</strong> 每年 26.9%。</p>
<p>Raytron Technology Ltd. 展示了强劲的增长潜力，预计年收益增长为 26.9%，超过更广泛的中国市场。最近的产品创新，如其先进的汽车红外夜视系统，突显了其对技术进步和市场扩展的承诺。尽管预测的股本回报率较低，为 15.3%，但 Raytron 的收入预计将以每年 16.1% 的速度增长，超过全国平均水平，得益于强劲的过去收益增长和在自动驾驶和安全解决方案等新兴领域的战略合作。</p>
<ul>
<li>点击这里访问我们关于 Raytron Technology Ltd 的完整增长分析报告，以了解其动态。</li>
<li>我们的估值报告显示 Raytron Technology Ltd 可能被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/955d9b28-ce5a-4aa7-b35b-3a914196153f/chart/ownership-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/955d9b28-ce5a-4aa7-b35b-3a914196153f/chart/ownership-breakdown"/></p>
<p>SHSE:688002 截至 2025 年 9 月的持股结构</p>
<h2>豆神（北京）教育科技 (SZSE:300010)</h2>
<p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> 豆神（北京）教育科技专注于提供教育技术解决方案，市值为 171.1 亿元人民币。</p>
<p><strong>运营：</strong> 该公司的收入部分包括信息技术服务，产生了 8.7606 亿元人民币的收入。</p>
<p><strong>内部持股：</strong> 24.1%</p>
<p><strong>收益增长预测：</strong> 每年 43%。</p>
<p>豆神（北京）教育科技展现出强劲的增长前景，预计年收益和收入分别增长 43% 和 42.8%，均超过中国市场的平均水平。截至 2025 年 6 月 30 日的半年度收益显示，销售额从去年 3.2639 亿元大幅增长至 4.4572 亿元，同时净收入也有所改善。尽管高非现金收益影响了质量指标，但内部持股仍是其战略方向的关键因素。</p>
<ul>
<li>在这份增长报告中解锁我们对豆神（北京）教育科技股票分析的全面见解。</li>
<li>我们编制的估值报告表明豆神（北京）教育科技当前的价格可能被高估。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7038ab7e-146e-4282-af7b-ae5545fd9fc7/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7038ab7e-146e-4282-af7b-ae5545fd9fc7/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300010 截至 2025 年 9 月的收益和收入增长</p>
<h2>让它发生</h2>
<ul>
<li>点击这里访问我们完整的 616 家高内部持股的快速增长亚洲公司的索引。</li>
<li>准备尝试其他投资风格吗？这 12 家公司在 COVID 之后生存并蓬勃发展，具备应对特朗普关税的正确要素。在您的投资组合感受到贸易战的压力之前，了解原因。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也不考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具如公司和/或信托实体间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>

零跑汽车

豆神教育

<p>截至 2025 年 9 月，亚洲市场正在经历增长，特别是在中国和日本。拥有高内部持股的公司被视为稳定的投资选择。值得注意的公司包括浙江零跑汽车科技、Seers Technology 和豆神（北京）教育科技，它们都显示出显著的盈利增长。例如，豆神预计年盈利增长 43%。然而，尽管增长潜力强劲，一些公司可能被高估。此分析强调了在当前经济环境中，内部持股在对齐管理层与股东利益方面的重要性</p>

<p>As of September 2025, Asian markets have been navigating a complex landscape marked by global economic shifts and local developments, with Chinese stock markets showing gains amid high domestic liquidity and Japan's indices rising despite tempered interest rate expectations. In this environment, companies with strong insider ownership can often provide a sense of stability and alignment between management and shareholder interests, making them attractive options for investors seeking growth opportunities in the region.</p>
<div class="lb-trans"><p>截至 2025 年 9 月，亚洲市场正在应对一个复杂的环境，受全球经济变化和地方发展影响，中国股市在国内流动性充裕的情况下出现上涨，而日本的指数在利率预期减弱的情况下也有所上升。在这种环境下，拥有强大内部持股的公司往往能够提供稳定性，并使管理层与股东利益保持一致，因此对寻求区域增长机会的投资者具有吸引力。</p>
</div><h3>Top 10 Growth Companies With High Insider Ownership In Asia</h3>
<div class="lb-trans"><h3>亚洲高内部持股的十大成长公司</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Insider Ownership</strong></td>
<td><strong>Earnings Growth</strong></td>
</tr>
<tr>
<td>Zhejiang Leapmotor Technology (SEHK:9863)</td>
<td>14.6%</td>
<td>57.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>84.6%</td>
</tr>
<tr>
<td>PharmaResearch (KOSDAQ:A214450)</td>
<td>35%</td>
<td>30.9%</td>
</tr>
<tr>
<td>Oscotec (KOSDAQ:A039200)</td>
<td>12.7%</td>
<td>104.1%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>30.3%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>35.5%</td>
<td>34%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.5%</td>
<td>24.9%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>35.2%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>11.8%</td>
<td>50.7%</td>
</tr>
<tr>
<td>Ascentage Pharma Group International (SEHK:6855)</td>
<td>12.8%</td>
<td>91.9%</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名称</strong></td>
<td><strong>内部持股</strong></td>
<td><strong>收益增长</strong></td>
</tr>
<tr>
<td>浙江零跑科技 (SEHK:9863)</td>
<td>14.6%</td>
<td>57.1%</td>
</tr>
<tr>
<td>Seers Technology (KOSDAQ:A458870)</td>
<td>33.9%</td>
<td>84.6%</td>
</tr>
<tr>
<td>PharmaResearch (KOSDAQ:A214450)</td>
<td>35%</td>
<td>30.9%</td>
</tr>
<tr>
<td>Oscotec (KOSDAQ:A039200)</td>
<td>12.7%</td>
<td>104.1%</td>
</tr>
<tr>
<td>Novoray (SHSE:688300)</td>
<td>23.6%</td>
<td>30.3%</td>
</tr>
<tr>
<td>Laopu Gold (SEHK:6181)</td>
<td>35.5%</td>
<td>34%</td>
</tr>
<tr>
<td>J&amp;V Energy Technology (TWSE:6869)</td>
<td>17.5%</td>
<td>24.9%</td>
</tr>
<tr>
<td>Gold Circuit Electronics (TWSE:2368)</td>
<td>31.4%</td>
<td>35.2%</td>
</tr>
<tr>
<td>Fulin Precision (SZSE:300432)</td>
<td>11.8%</td>
<td>50.7%</td>
</tr>
<tr>
<td>Ascentage Pharma Group International (SEHK:6855)</td>
<td>12.8%</td>
<td>91.9%</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 616 stocks from our Fast Growing Asian Companies With High Insider Ownership screener.</p>
<div class="lb-trans"><p>点击这里查看我们快速增长的亚洲高内部持股公司筛选器中的 616 只股票的完整列表。</p>
</div><p>Here's a peek at a few of the choices from the screener.</p>
<div class="lb-trans"><p>以下是筛选器中的一些选择。</p>
</div><h2>Alibaba Health Information Technology (SEHK:241)</h2>
<div class="lb-trans"><h2>阿里巴巴健康信息技术 (SEHK:241)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Alibaba Health Information Technology Limited operates in Mainland China and Hong Kong, focusing on pharmaceutical direct sales, a pharmaceutical e-commerce platform, and healthcare and digital services, with a market cap of HK$107.32 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 阿里巴巴健康信息技术有限公司在中国大陆和香港运营，专注于药品直销、药品电子商务平台以及医疗和数字服务，市值为 1073.2 亿港元。</p>
</div><p><strong>Operations:</strong> The company generates revenue of CN¥30.60 billion from its distribution and development of pharmaceutical and healthcare operations.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司通过其药品和医疗运营的分销和开发产生了 306 亿元人民币的收入。</p>
</div><p><strong>Insider Ownership:</strong> 19.3%</p>
<div class="lb-trans"><p><strong>内部持股：</strong> 19.3%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 20.3% p.a.</p>
<div class="lb-trans"><p><strong>收益增长预测：</strong> 每年 20.3%。</p>
</div><p>Alibaba Health Information Technology trades at a significant discount to its estimated fair value and is expected to see substantial earnings growth of over 20% annually. Despite slower revenue growth projections at 9.9% per year, it surpasses the Hong Kong market average. The company has experienced strong past earnings performance, growing by 62.1% last year, but faces challenges with low forecasted return on equity and large one-off items affecting earnings quality.</p>
<div class="lb-trans"><p>阿里巴巴健康信息技术的交易价格显著低于其估计的公允价值，预计年收益增长将超过 20%。尽管收入增长预测为每年 9.9% 较慢，但仍超过香港市场的平均水平。该公司过去的收益表现强劲，去年增长了 62.1%，但面临着低预测股本回报率和大量一次性项目影响收益质量的挑战。</p>
</div><ul>
<li>Take a closer look at Alibaba Health Information Technology's potential here in our earnings growth report.</li>
<li>The analysis detailed in our Alibaba Health Information Technology valuation report hints at an inflated share price compared to its estimated value.</li>
</ul>
<div class="lb-trans"><ul>
<li>在我们的收益增长报告中更详细地了解阿里巴巴健康信息技术的潜力。</li>
<li>我们的阿里巴巴健康信息技术估值报告中的分析暗示其股价相较于估计价值被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f0d30b15-6b0d-4c3b-a813-701ae085f025/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/f0d30b15-6b0d-4c3b-a813-701ae085f025/chart/earnings-and-revenue-growth"/></p>
<p>SEHK:241 Earnings and Revenue Growth as at Sep 2025</p>
<div class="lb-trans"><p>SEHK:241 截至 2025 年 9 月的收益和收入增长</p>
</div><h2>Raytron TechnologyLtd (SHSE:688002)</h2>
<div class="lb-trans"><h2>Raytron Technology Ltd (SHSE:688002)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Raytron Technology Co., Ltd. specializes in the R&amp;D, design, manufacturing, and sales of uncooled infrared imaging and MEMS sensor technology in China, with a market cap of CN¥39.97 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> Raytron Technology Co., Ltd. 专注于中国的无冷却红外成像和 MEMS 传感器技术的研发、设计、制造和销售，市值为 399.7 亿元人民币。</p>
</div><p><strong>Operations:</strong> Raytron Technology Co., Ltd. generates revenue primarily through its uncooled infrared imaging and MEMS sensor technology operations in China.</p>
<div class="lb-trans"><p><strong>运营：</strong> Raytron Technology Co., Ltd. 主要通过其在中国的无冷却红外成像和 MEMS 传感器技术运营产生收入。</p>
</div><p><strong>Insider Ownership:</strong> 25.7%</p>
<div class="lb-trans"><p><strong>内部持股：</strong> 25.7%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 26.9% p.a.</p>
<div class="lb-trans"><p><strong>收益增长预测：</strong> 每年 26.9%。</p>
</div><p>Raytron Technology Ltd. demonstrates robust growth potential with forecasted annual earnings growth of 26.9%, outpacing the broader Chinese market. Recent product innovations, such as their advanced automotive infrared night vision systems, highlight their commitment to technological advancement and market expansion. Despite a lower return on equity forecast of 15.3%, Raytron's revenue is expected to grow at 16.1% annually, surpassing the national average, supported by strong past earnings growth and strategic partnerships in emerging sectors like autonomous driving and security solutions.</p>
<div class="lb-trans"><p>Raytron Technology Ltd. 展示了强劲的增长潜力，预计年收益增长为 26.9%，超过更广泛的中国市场。最近的产品创新，如其先进的汽车红外夜视系统，突显了其对技术进步和市场扩展的承诺。尽管预测的股本回报率较低，为 15.3%，但 Raytron 的收入预计将以每年 16.1% 的速度增长，超过全国平均水平，得益于强劲的过去收益增长和在自动驾驶和安全解决方案等新兴领域的战略合作。</p>
</div><ul>
<li>Click here and access our complete growth analysis report to understand the dynamics of Raytron TechnologyLtd.</li>
<li>Our valuation report here indicates Raytron TechnologyLtd may be overvalued.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里访问我们关于 Raytron Technology Ltd 的完整增长分析报告，以了解其动态。</li>
<li>我们的估值报告显示 Raytron Technology Ltd 可能被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/955d9b28-ce5a-4aa7-b35b-3a914196153f/chart/ownership-breakdown" alt="" original-src="https://images.simplywall.st/company/955d9b28-ce5a-4aa7-b35b-3a914196153f/chart/ownership-breakdown"/></p>
<p>SHSE:688002 Ownership Breakdown as at Sep 2025</p>
<div class="lb-trans"><p>SHSE:688002 截至 2025 年 9 月的持股结构</p>
</div><h2>Doushen (Beijing) Education &amp; Technology (SZSE:300010)</h2>
<div class="lb-trans"><h2>豆神（北京）教育科技 (SZSE:300010)</h2>
</div><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 成长评级：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Doushen (Beijing) Education &amp; Technology focuses on providing educational technology solutions and has a market cap of CN¥17.11 billion.</p>
<div class="lb-trans"><p><strong>概述：</strong> 豆神（北京）教育科技专注于提供教育技术解决方案，市值为 171.1 亿元人民币。</p>
</div><p><strong>Operations:</strong> The company's revenue segment includes Information Technology Service, generating CN¥876.06 million.</p>
<div class="lb-trans"><p><strong>运营：</strong> 该公司的收入部分包括信息技术服务，产生了 8.7606 亿元人民币的收入。</p>
</div><p><strong>Insider Ownership:</strong> 24.1%</p>
<div class="lb-trans"><p><strong>内部持股：</strong> 24.1%</p>
</div><p><strong>Earnings Growth Forecast:</strong> 43% p.a.</p>
<div class="lb-trans"><p><strong>收益增长预测：</strong> 每年 43%。</p>
</div><p>Doushen (Beijing) Education &amp; Technology shows strong growth prospects with forecasted annual earnings and revenue increases of 43% and 42.8%, respectively, outpacing the Chinese market averages. Recent earnings for the half year ended June 30, 2025, indicate significant sales growth to CNY 445.72 million from CNY 326.39 million a year ago, alongside improved net income. Despite high non-cash earnings impacting quality metrics, insider ownership remains a key factor in its strategic direction.</p>
<div class="lb-trans"><p>豆神（北京）教育科技展现出强劲的增长前景，预计年收益和收入分别增长 43% 和 42.8%，均超过中国市场的平均水平。截至 2025 年 6 月 30 日的半年度收益显示，销售额从去年 3.2639 亿元大幅增长至 4.4572 亿元，同时净收入也有所改善。尽管高非现金收益影响了质量指标，但内部持股仍是其战略方向的关键因素。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Doushen (Beijing) Education &amp; Technology stock in this growth report.</li>
<li>The valuation report we've compiled suggests that Doushen (Beijing) Education &amp; Technology's current price could be inflated.</li>
</ul>
<div class="lb-trans"><ul>
<li>在这份增长报告中解锁我们对豆神（北京）教育科技股票分析的全面见解。</li>
<li>我们编制的估值报告表明豆神（北京）教育科技当前的价格可能被高估。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/7038ab7e-146e-4282-af7b-ae5545fd9fc7/chart/earnings-and-revenue-growth" alt="" original-src="https://images.simplywall.st/company/7038ab7e-146e-4282-af7b-ae5545fd9fc7/chart/earnings-and-revenue-growth"/></p>
<p>SZSE:300010 Earnings and Revenue Growth as at Sep 2025</p>
<div class="lb-trans"><p>SZSE:300010 截至 2025 年 9 月的收益和收入增长</p>
</div><h2>Make It Happen</h2>
<div class="lb-trans"><h2>让它发生</h2>
</div><ul>
<li>Click here to access our complete index of 616 Fast Growing Asian Companies With High Insider Ownership.</li>
<li>Ready To Venture Into Other Investment Styles? These 12 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.</li>
</ul>
<div class="lb-trans"><ul>
<li>点击这里访问我们完整的 616 家高内部持股的快速增长亚洲公司的索引。</li>
<li>准备尝试其他投资风格吗？这 12 家公司在 COVID 之后生存并蓬勃发展，具备应对特朗普关税的正确要素。在您的投资组合感受到贸易战的压力之前，了解原因。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，内容具有一般性。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不构成财务建议。</strong> 它不构成买入或卖出任何股票的推荐，也不考虑您的目标或财务状况。我们的目标是为您提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。该分析仅考虑内部人士直接持有的股票，不包括通过其他工具如公司和/或信托实体间接持有的股票。所有预测的收入和收益增长率均以年化（每年）增长率的形式表示，时间范围为 1-3 年。</em></p>
</div>

2025 年 9 月亚洲内部持股比例高的成长型公司